Some new drugs aren’t actually ‘new’ – pharmaceutical companies exploit patents and raise prices for patients, but data transparency can help protect innovation
- Written by Lucy Xiaolu Wang, Assistant Professor, Department of Resource Economics, UMass Amherst
When companies file hundreds of patents for a single drug, affordable versions can remain out of reach for years.pilli/iStock via Getty Images PlusPharmaceutical innovation saves lives. But not every “new” drug is truly new.
Patents are designed to reward breakthrough inventions by granting the inventors temporary monopoly rights to...







